We are live on ! Find out more
REVBW icon

Revelation Biosciences Warrant
REVBW

17 hedge funds and large institutions have $33.4K invested in Revelation Biosciences Warrant in 2023 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

350% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 2

55% more funds holding

Funds holding: 11 → 17 (+6)

42% more capital invested

Capital invested by funds: $23.6K → $33.4K (+$9.86K)

0.91% more ownership

Funds ownership: 7.71% → 8.62% (+0.91%)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders
17
Holders Change
+6
Holders Change %
+54.55%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
1
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Walleye Capital
Walleye Capital
New York
+$4.69K
2
ICM
Ionic Capital Management
New York
+$4.3K
3
Walleye Trading
Walleye Trading
New York
+$2.63K
4
BRF
B. Riley Financial
California
+$2.51K
5
CAC
Cowen and Company
New York
+$2.47K

Top Sellers

Rank Fund Capital Flow
1
OCAM
Owl Creek Asset Management
New York
-$3.93K
2
PAMP
Polar Asset Management Partners
Ontario, Canada
-$1.35K
3
Jane Street
Jane Street
New York
-$46
Name Holding Trade Value Shares
Change 		Change in
Stake
LA
1
Linden Advisors
New York
$12.8K – – –
YCM
2
Yakira Capital Management
Connecticut
$4K – – –
Walleye Capital
3
Walleye Capital
New York
$3.03K +$4.69K +187,001 New
ICM
4
Ionic Capital Management
New York
$2.77K +$4.3K +171,189 New
Walleye Trading
5
Walleye Trading
New York
$1.7K +$2.63K +104,990 New
BRF
6
B. Riley Financial
California
$1.62K +$2.51K +100,000 New
CAC
7
Cowen and Company
New York
$1.59K +$2.47K +98,296 New
Jane Street
8
Jane Street
New York
$1.31K -$46 -1,814 -2%
AC
9
Ayrton Capital
Connecticut
$1.22K – – –
WAM
10
Wolverine Asset Management
Illinois
$1.2K – – –
PVI
11
Pine Valley Investments
New Jersey
$786 +$1.1K +43,865 New
PFM
12
Privium Fund Management
Netherlands
$713 – – –
EPM
13
Equitec Proprietary Markets
Illinois
$324 – – –
Citadel Advisors
14
Citadel Advisors
Florida
$278 +$430 +17,139 New
UBS Group
15
UBS Group
Switzerland
$97 +$153 +6,089 New
OCAM
16
Owl Creek Asset Management
New York
– -$3.93K -300,000 Closed
PAMP
17
Polar Asset Management Partners
Ontario, Canada
– -$1.35K -98,296 Closed
FTUS
18
Flow Traders U.S.
New York
– +$10 +407 +3%
VF
19
Virtu Financial
New York
– +$743 +29,616 New

REVBW Hedge Fund Activity: Q1 2023 in Review

17 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Revelation Biosciences Warrant (REVBW) for Q1 2023, worth a combined $33.4K — up 42% from $23.6K a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new REVBW positions and 2 closed out — a net gain of 7 holders — while 1 added to existing stakes and 1 trimmed.

The largest buyer was Walleye Capital, opening a new position worth an estimated $4.69K. The largest seller was Owl Creek Asset Management, exiting entirely with an estimated $3.93K sold.

  • 17 institutional investors held Revelation Biosciences Warrant (REVBW) as of Q1 2023, up from 11 in Q4 2022.
  • Funds reported $33.4K of Revelation Biosciences Warrant stock for Q1 2023, up 42% quarter-over-quarter.
  • 9 funds opened new Revelation Biosciences Warrant positions in Q1 2023 and 2 closed out, a net change of +7 holders.
  • The largest Revelation Biosciences Warrant buyer in Q1 2023 was Walleye Capital, an estimated $4.69K added.
  • The largest Revelation Biosciences Warrant seller in Q1 2023 was Owl Creek Asset Management, an estimated $3.93K sold.

Based on aggregated 13F filings for Q1 2023.